BriteScan, LLC is a woman-owned technology company founded in the San Francisco Bay Area in 2018 by Dr. Danica T. Harbaugh Reynaud, PhD and Daniel Reynaud. The company is currently owned by Dr. Danica Reynaud, who serves as the Chief Executive Officer. BriteScan currently holds three US patents and multiple pending worldwide related to devices used for material testing using computer analysis of images. The company continues to build its portfolio and case studies using its working device, the iVeris- a simple portable device for instant material verification using imaging and cloud-based computer vision software. The iVeris has been successfully tested at major natural products companies such as McCormick & Company and Amway and government agencies such as the FDA for a wide range of applications and materials.
Danica is an experienced scientist, inventor, and entrepreneur passionate about developing and commercializing disruptive and innovative technologies from AI to DNA. She was a pioneer in the use of Next Generation DNA Sequencing technologies for botanicals and founded the first contract lab specializing in that field, AuthenTechnologies, LLC, in 2010. In 2015, AuthenTechnologies was acquired by the global non-profit organization NSF International, where she then worked as the Global Director of Scientific Innovation. In 2018 Danica co-founded BriteScan LLC to create more affordable, rapid and cutting-edge testing technologies. She has a B.A. and Ph.D. in Integrative Biology from UC Berkeley, and completed her postdoctoral fellowship at the Smithsonian Institution's National Museum of Natural History. She established a quality control DNA lab at the botanical pharmaceutical company Bionovo before venturing into start-ups.
Serge is a pioneer in the field of Computer Vision and professor of Computer Science at the University of Copenhagen, where he also serves as the head of the Pioneer Centre for Artificial Intelligence. Previously, he was a professor of Computer Science at Cornell University, an Associate Dean at Cornell Tech, and a member of the Visiting Faculty program at Google. His research interests include Computer Vision, Machine Learning, Augmented Reality, and Human-in-the-Loop Computing. He is also a co-founder of several companies including Digital Persona, which created the first mass market fingerprint recognition device. He is a recipient of the NSF CAREER Award, the Alfred P. Sloan Research Fellowship, the MIT Technology Review “Innovators Under 35” Award, and the Helmholtz Prize for fundamental contributions in Computer Vision.
Bruce has been CMO of two $10B+ global companies AMAT/AKT and LG Display, and held executive roles at four smaller companies in various tech spaces including CEO of a fabless semiconductor start-up. He has helped large companies raise over $3.7B, including LPL’s $1B IPO, and smaller companies over $60m. Specializing in the commercialization and modernization of great technology, he has helped bring multiple med-tech, sci-tech, and electronic materials companies to market. He holds degrees in Physics and Biophysics from Princeton and UC Berkeley, and has been on many BODs including presently QD maker Nanosys, and previously 5 public companies.
Mark is an executive with extensive leadership skills, including 15+ years of P&L responsibility, senior managerial and executive experience (technical, operational and quality) in the food & beverage industry. He has been an advisor to technology companies looking to grow in the quality/safety space. He is currently the President of MC Squared Consulting. Previously Mark was Executive VP of Matrix Sciences, Corporate VP of R&D at Siliker, and CEO of QC Laboratories. He has a B.S. in Microbiology from University of Georgia and an M.S.A. Business from Columbus State University.
Meredith is the Associate Director of Microscopy & Image analysis at Denali Therapeutics in South San Francisco, with over 15 years’ experience building and leading bioimaging platforms. She has developed numerous quantitative imaging tools for exploring cellular mechanisms, and throughout her career has been exploring strategies for leveraging and integrating big image data in biological research (morphological screens, whole-organ imaging, high content image data, spatial transcriptomics and proteomics). She received a B.A. in Developmental Biology from Reed College in Portland and a Ph.D in Microbiology from the University of Virginia, Charlottesville. She has directed Imaging and Biocomputing facilities in Singapore and at the Gladstone Institutes in San Francisco, taught and directed graduate courses and imaging workshops, and served in leadership roles with the Association of Biomolecular Resource Facilities, the Western Association of Core Directors, and is a founder and executive board member of BioImaging North America.